These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 15791619

  • 1. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P.
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [Abstract] [Full Text] [Related]

  • 2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 3. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C, Cochran E, Javor E, Young J, Depaoli AM, Gorden P.
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [Abstract] [Full Text] [Related]

  • 4. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
    Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, Kleiner DE, Gorden P.
    J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
    [Abstract] [Full Text] [Related]

  • 5. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.
    Hepatogastroenterology; 1999 Jul; 46(28):2422-5. PubMed ID: 10522010
    [Abstract] [Full Text] [Related]

  • 6. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, Emick D, Lok AS, Conjeevaram HS.
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [Abstract] [Full Text] [Related]

  • 7. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
    Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J.
    Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
    [Abstract] [Full Text] [Related]

  • 8. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD, Tilg H, Moschen AR, Purdie DM, Demetris AJ, Clouston AD.
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [Abstract] [Full Text] [Related]

  • 9. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB, Bhathal PS, O'Brien PE.
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [Abstract] [Full Text] [Related]

  • 10. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z.
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [Abstract] [Full Text] [Related]

  • 11. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
    Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV.
    Am J Gastroenterol; 2003 Dec; 98(12):2771-6. PubMed ID: 14687831
    [Abstract] [Full Text] [Related]

  • 12. Serum leptin levels in patients with nonalcoholic steatohepatitis.
    Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K.
    Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
    [Abstract] [Full Text] [Related]

  • 13. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J, Altun E, Zacks S, Armao DM, Woosley JT, Semelka RC.
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
    Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH.
    Hepatology; 2004 Jan; 39(1):188-96. PubMed ID: 14752837
    [Abstract] [Full Text] [Related]

  • 15. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A, Zahriya K, Willes EB.
    Obes Surg; 2005 Jan; 15(10):1418-23. PubMed ID: 16354521
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO, Park SH, Park CH, Han TH, Yoo KS, Kim JH, Lee MS, Kim DJ, Park CK, Cho HD.
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [Abstract] [Full Text] [Related]

  • 17. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB.
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [Abstract] [Full Text] [Related]

  • 18. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 19. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S, López-Alvarenga JC, Uribe-Uribe NO, Herrera-Hernández M, González-Barranco J.
    Rev Invest Clin; 2005 Dec; 57(4):505-12. PubMed ID: 16315634
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
    Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P.
    Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.